ID: ALA5282405

Max Phase: Preclinical

Molecular Formula: C16H14N2O4

Molecular Weight: 298.30

Associated Items:

Representations

Canonical SMILES:  O=C(CCCN1C(=O)c2cccc3cccc(c23)C1=O)NO

Standard InChI:  InChI=1S/C16H14N2O4/c19-13(17-22)8-3-9-18-15(20)11-6-1-4-10-5-2-7-12(14(10)11)16(18)21/h1-2,4-7,22H,3,8-9H2,(H,17,19)

Standard InChI Key:  GBPSCCPAXYTNMB-UHFFFAOYSA-N

Associated Targets(non-human)

Toxoplasma gondii 4585 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.30Molecular Weight (Monoisotopic): 298.0954AlogP: 1.72#Rotatable Bonds: 4
Polar Surface Area: 86.71Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.91CX Basic pKa: CX LogP: 1.10CX LogD: 1.09
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.51Np Likeness Score: -0.65

References

1. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X..  (2021)  Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations.,  64  (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569]

Source